New trademark entries in Canada and Europe, reported Wednesday, expand the documentary evidence for Garmin's unannounced CIRQA recovery band — and the language in both filings points toward a sensor type absent from every screenless competitor currently on the market. The filings describe a device capable of measuring recovery from physical and emotional stress, a pairing that optical heart-rate sensors cannot replicate and that would give CIRQA a hardware differentiator before its first official announcement.

The Garmin CIRQA has been accumulating pre-launch evidence since a product listing accidentally appeared on Garmin's own website in January 2026 and was quickly pulled. Since it surfaced, a Garmin CIRQA trademark filing at the USPTO confirmed the product's name and scope. Regulatory clearances have accumulated across four jurisdictions, Garmin's own Connect app has been updated to support a screenless device, and the trademark footprint has grown from the United States to Canada and Europe. What the latest filings add is not timing intelligence — it is sensor intelligence, and it arrives precisely when athletes evaluating a recovery band purchase need it most.

What the Canadian and European Filings Actually Say

The Canadian Intellectual Property Office received Garmin's CIRQA trademark application — number 2483360 — on June 19, 2026. The European Union Intellectual Property Office received application 019384825 on June 23. Both filings use identical product language and claim priority back to Garmin's original USPTO application, number 99670310, filed February 25. Under international trademark rules, that priority date means the European and Canadian registrations are treated as having been filed in February even though they arrived in June. Both the CIPO and EUIPO entries are detailed in reporting on the new Canadian and European trademark filings.

The operative product description covers wearable devices and instruments designed to measure and analyze the body's physical parameters, physiological data, bio-signals, and bodily behavior — and, specifically, recovery from physical and emotional stress, human alertness level, and performance, all for non-medical and non-therapeutic purposes.

The deliberate separation of physical and emotional stress recovery is the phrase that matters. Recovery from physical stress is measurable by any optical heart-rate sensor through heart rate variability — the beat-to-beat timing variation that reflects autonomic nervous system balance after exertion. Recovery from emotional stress is different. It points toward electrodermal activity (EDA), the measurement of small shifts in skin electrical conductance caused by sweat gland activity controlled by the sympathetic nervous system — the branch that drives fight-or-flight responses. EDA cannot be captured with light. It requires direct electrode contact with the skin.

Trademark filings are legal documents specifying the intended scope of a product's use — not hardware specifications confirming what will ship. The CIRQA may ultimately launch without a dedicated EDA electrode, achieving its stress-recovery language through software modeling of heart rate variability and skin temperature alone, as some existing devices do. Garmin has not officially announced the product or confirmed any sensor specifications. What the filing establishes is that Garmin's legal team used language precise enough to cover EDA sensing — and legal teams do not typically reach for that language when their hardware cannot support it.

Why Optical Sensors Cannot Capture What EDA Measures

Heart rate variability and electrodermal activity are measuring different branches of the same nervous system. HRV captures the balance between the sympathetic and parasympathetic branches of the autonomic nervous system through the time intervals between heartbeats. It is an integrative, systemic signal: when HRV is suppressed, it reflects reduced cardiac autonomic flexibility, which can indicate fatigue, poor sleep, illness, or psychological stress — but it cannot tell you which one is responsible.

EDA measures the sympathetic nervous system's direct effect on sweat glands. When the brain's arousal centers activate — whether from a difficult conversation, a race-day adrenaline spike, or accumulated work anxiety — the sympathetic nervous system fires, sweat gland activity rises, and skin conductance increases within one to three seconds. Because EDA is not under conscious control, it captures stress responses the user may not subjectively register. Hugo Critchley, Chair of Psychiatry at Brighton and Sussex Medical School, has described EDA as "a sensitive psychophysiological index of changes in autonomic sympathetic arousal that are integrated with emotional and cognitive states."

The combination of HRV and EDA offers something neither provides alone. Low HRV plus elevated EDA suggests acute sympathetic arousal on top of systemic fatigue — the physiological signature of a stressful life period on an already tired body. Low HRV alone, without an EDA signal, cannot make that distinction. No current mass-market screenless band — not Whoop, not Samsung Galaxy Ring, not the Fitbit Air — collects both signals simultaneously in a wrist-worn form factor.

What the Sensor Still Needs to Prove

The gap between EDA capability and EDA reliability on the wrist is the engineering challenge the trademark language does not address.

EDA research establishes optimal electrode placement at the palms and fingers, where eccrine sweat gland density runs between 200 and 600 glands per square centimeter. Wrist sweat gland density is approximately five times lower. The practical consequence is measurable: a 2021 peer-reviewed study found that only 30 percent of skin conductance responses detectable at the fingers register simultaneously at the wrist outside of a stress task. During an active stress task, that figure rises to 72 percent.

This is not a fatal limitation — it is an engineering tradeoff that determines what EDA can realistically deliver on a wrist band versus what clinical-standard palm electrodes can deliver. Motion artifacts from exercise create additional noise in wrist EDA signals. Environmental factors including temperature and humidity affect conductance baselines. Researchers specifically studying wrist-worn EDA in consumer devices have noted that reliability must be further investigated, particularly when raw data collection is combined with the preprocessing techniques that consumer devices apply.

Garmin has developed three plausible approaches for integrating EDA into CIRQA. Analysis of the filings and prior regulatory evidence suggests the device could pair its existing Elevate optical sensor with a discrete EDA electrode module on the inner band surface; a next-generation Elevate sensor could incorporate bioelectrical sensing as an additional capability; or ECG and EDA electrode functions could share a single set of inner-surface contacts, a form of ECG and EDA electrode integration that published research has already demonstrated is technically feasible.

What published work on multi-sensor wearables does confirm is that combining EDA with photoplethysmography (optical heart rate) and accelerometry substantially improves stress classification accuracy — reaching 77 to 92 percent in binary stress detection tasks. CIRQA is expected to include Garmin's optical sensor stack alongside any EDA capability, which is exactly the fusion architecture the literature validates.

A Pattern of Pre-Launch IP Activity

The June trademark filings follow a pre-launch IP sequence that spans four jurisdictions and seven months. A USPTO trademark application was filed February 25, 2026 — one month after the accidental product listing appeared on Garmin's website. The CIPO and EUIPO filings arrived in June, extending trademark protection across North America and Europe.

Separately from the trademark activity, CIRQA has cleared regulatory review with the Federal Communications Commission in the United States, Singapore's Infocomm Media Development Authority, and the UAE's Telecommunications and Digital Government Regulatory Authority, as documented across FCC, Singapore, and UAE clearances. Regulatory clearances at the distributor level across three jurisdictions indicate hardware that is production-ready for international retail distribution, not a product still in early development. Garmin Connect version 5.25, released May 20, 2026, added dedicated code support for a screenless paired device — including phone-side data processing services that replace the controls a screen would normally handle.

One detail the trademark pattern surfaces: there is no corresponding Canadian or European trademark filing for Garmin's other February 2026 filing, a name called Muscle Battery, whose USPTO wording pointed toward software and algorithms for muscle oxygen saturation. Muscle Battery's absence from the international expansion suggests Garmin is treating the two names differently — and that CIRQA is the product being positioned for a global release while Muscle Battery may be a feature, metric, or platform name rather than a standalone product identity.

Competitive Timing and What It Means for Buyers

Garmin's Q1 2026 earnings showed Fitness as the fastest-growing segment — up 42 percent year-on-year — with CEO Cliff Pemble forecasting "stronger performance in the back half of the year due to the timing of product launches." CIRQA, the Fenix 9, and the Enduro 4 are all expected in the H2 2026 window, making this Garmin's most significant product year in recent memory.

The recovery band market has changed considerably during the months CIRQA has been accumulating its pre-launch evidence. Fitbit Air, launched May 7 at $99 with no mandatory subscription, established a new price floor for the screenless category and drew direct comparisons to Whoop's subscription model — currently running $199 to $359 per year depending on tier. Garmin's current Connect+ subscription sits at $6.99 per month and is optional: core recovery metrics including Body Battery, HRV Status, and sleep tracking remain free for all users. That model will likely apply to CIRQA as well, though Garmin has not confirmed it.

Grey-market retailer listings from Ukraine surfaced a price of approximately 19,999 hryvnias, translating to roughly $370 to $500 at current exchange rates. Analyst modelling of CIRQA's positioning within Garmin's existing product lineup and against competitive pricing pressure has produced a defensible estimated range of $249 to $349. None of these figures is official Garmin pricing. If EDA sensing is confirmed at launch, the hardware differentiation would support a premium price that a device offering only optical sensing could not justify against a $99 Fitbit Air.

For existing Garmin watch owners, the CIRQA fills a specific gap that no current product in the lineup addresses: 24/7 biometric collection from a lightweight band during the hours when a GPS multisport watch is charging. Pairing CIRQA with a Fenix 8 or Forerunner 970 would allow the band to handle overnight sleep and recovery data while the watch charges, without any gap in HRV or stress tracking. Published analysis suggests the pairing could also enable more precise workout recognition during training sessions, providing additional sensor data that improves the accuracy of post-workout recovery scores in Garmin Connect.

Does Garmin Need EDA to Win This Category?

Whoop's stress tracking, and the approach used by Samsung Galaxy Watch and Google Fitbit Air, derives stress scores from a combination of HRV, resting heart rate, skin temperature, and accelerometry. These devices have built substantial user bases without electrode-based EDA sensing. The absence of EDA has not prevented any of these products from delivering commercial stress scores that users find actionable.

What EDA adds is a different kind of signal: one that captures the autonomic nervous system's acute responses in near-real time rather than integrating them across hours of collected cardiac data. For athletes managing psychological stress — the cumulative strain of competition schedules, travel, and professional demands alongside physical training load — EDA provides a measurement channel that HRV-based systems can only approximate through inference.

Whether Garmin ultimately includes a dedicated EDA electrode in the CIRQA, or whether the trademark language reflects a broader software framing of emotional stress recovery built on existing HRV infrastructure, the competitive picture has sharpened. The CIPO and EUIPO filings confirm that Garmin's stated ambition for CIRQA goes beyond replicating what existing recovery bands already offer — and that ambition is now documented across three trademark jurisdictions covering the company's most important markets.

Frequently Asked Questions

What is EDA, and why does it matter for stress tracking?

EDA — electrodermal activity, also known as galvanic skin response — measures changes in the skin's electrical conductance caused by sweat gland activity controlled by the sympathetic nervous system. Unlike heart rate variability, which captures an integrative picture of autonomic balance that reflects both physical and psychological load without distinguishing them, EDA responds specifically to acute sympathetic arousal — emotional stress, sudden anxiety, or adrenaline events. A wearable that combines EDA with HRV can theoretically identify whether suppressed recovery reflects physical fatigue, psychological stress, or both simultaneously, which HRV alone cannot determine.

Does the trademark filing confirm the CIRQA will have an EDA sensor?

No. Trademark filings are legal documents defining the intended scope of a product's use — not hardware specifications. The CIPO and EUIPO filings describe a device capable of measuring recovery from physical and emotional stress, language that is most naturally explained by EDA sensing; but Garmin could deliver an emotional stress score through HRV modeling and skin temperature rather than a dedicated EDA electrode. Sensor specifications will not be known until Garmin officially announces the product. What is confirmed is that Garmin chose language precise enough to cover EDA capability, which trademark attorneys do not typically do without a corresponding hardware basis.

If the CIRQA does have EDA, will wrist placement deliver reliable results?

This is the key engineering question. Sweat gland density on the wrist is approximately five times lower than on the palm or fingers — where clinical EDA research places electrodes. A peer-reviewed 2021 study found that only 30 percent of stress responses detectable at the fingers simultaneously register at the wrist during normal conditions; that figure rises to 72 percent during active stress. Consumer wrist EDA devices require substantial signal processing to compensate for the lower baseline density and motion artifacts from exercise. Multi-sensor fusion — combining EDA with optical heart rate and accelerometry — significantly improves accuracy, and CIRQA is expected to include Garmin's optical sensor stack alongside any EDA capability.

How does CIRQA compare to Whoop, Fitbit Air, and Samsung Galaxy Ring for stress tracking?

Whoop uses HRV and other physiological inputs to generate a recovery score but does not include a dedicated EDA electrode. Samsung Galaxy Watch approximates stress through HRV integration rather than true electrodermal measurement. Fitbit Air uses optical heart rate and HRV for stress inference; it also lacks an EDA electrode. If CIRQA ships with a genuine EDA sensor, it would become the first mass-market screenless recovery band to offer true electrodermal stress measurement — a hardware differentiator its current competitors do not have. The question is whether the wrist-placement signal quality is sufficient to deliver on that promise in real-world use.